Jeremy Pantin, MBBS, FACP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Speakers Bureau
    Date added:
    09/04/2024
    Date updated:
    09/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Sanofi
    Topic:
    Speakers Bureau
    Date added:
    09/04/2024
    Date updated:
    09/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Omeros
    Topic:
    Speakers Bureau
    Date added:
    09/04/2024
    Date updated:
    09/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Omeros
    Topic:
    Advisory Board
    Date added:
    09/04/2024
    Date updated:
    09/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Topic:
    Advisory Board
    Date added:
    09/04/2024
    Date updated:
    09/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Legend Biotech
    Topic:
    Advisory Board
    Date added:
    09/04/2024
    Date updated:
    09/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    MaaT Pharma
    Topic:
    Advisory Board
    Date added:
    09/04/2024
    Date updated:
    09/04/2024
Return to 2024 Summit on Hematological Cancers